Submitted by Anonymous (not verified) on 30 July 2026 - 12:40
Human medicines European public assessment report (EPAR): Mayzent, siponimod, Date of authorisation: 13/01/2020, Revision: 21, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Mayzent, siponimod, Date of authorisation: 13/01/2020, Revision: 21, Status: Authorised